Vivani Medical (VANI) vs. Its Competitors Head to Head Analysis

Vivani Medical (NASDAQ:VANI) is one of 59 public companies in the “Electromedical equipment” industry, but how does it contrast to its rivals? We will compare Vivani Medical to related companies based on the strength of its earnings, dividends, analyst recommendations, institutional ownership, profitability, valuation and risk.

Institutional & Insider Ownership

8.4% of Vivani Medical shares are owned by institutional investors. Comparatively, 46.2% of shares of all “Electromedical equipment” companies are owned by institutional investors. 55.6% of Vivani Medical shares are owned by company insiders. Comparatively, 10.9% of shares of all “Electromedical equipment” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of current recommendations and price targets for Vivani Medical and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	0	0	1	0	3.00
Vivani Medical Competitors	139	615	1590	23	2.63

Vivani Medical currently has a consensus target price of $7.00, suggesting a potential upside of 652.69%. As a group, “Electromedical equipment” companies have a potential upside of 30.43%. Given Vivani Medical’s stronger consensus rating and higher probable upside, equities analysts plainly believe Vivani Medical is more favorable than its rivals.

Earnings & Valuation

This table compares Vivani Medical and its rivals top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Vivani Medical	N/A	-$13.89 million	-2.38
Vivani Medical Competitors	$1.32 billion	$124.41 million	-1.82

Vivani Medical’s rivals have higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Vivani Medical and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-44.95%	-35.23%
Vivani Medical Competitors	-520.29%	-140.32%	-41.98%

Risk and Volatility

Vivani Medical has a beta of 2.6, meaning that its share price is 160% more volatile than the S&P 500. Comparatively, Vivani Medical’s rivals have a beta of 2.24, meaning that their average share price is 124% more volatile than the S&P 500.

Summary

Vivani Medical beats its rivals on 8 of the 13 factors compared.

About Vivani Medical

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.